This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system? How are we advanced prepping drugs? Are we making sure things are going well?
Pharmacists are well positioned to perform drug interaction checks, counsel patients on adherence and administration, and coordinate supportive care, including prophylaxis for infections (eg, granulocyte colony-stimulating factor, vaccines).
2 “I think what’s going to be really interesting with finerenone is [whether] it is an inpatient or an outpatient drug,” said Katherine Di Palo, PharmD, MBA, MS, senior director of transitional care excellence at Montefiore Medical Center in the Bronx, New York, referencing the time-to-benefit data in FINEARTS-HF.
So if patients are doing research about transplants, what they read and hear on the internet is that it’s all inpatient. As I said, if you read anywhere—especially, we've been doing this for 10 years now—it’s hard to believe there weren’t a lot of institutions doing outpatient transplants. And so they're like, “What do you mean?”
Related Videos Related Content Advertisement June 11th 2025 Perioperative Nivolumab Shows Long-Term EFS, Favorable OS in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2.
Pharmacists are central to these efforts, ensuring that pharmacogenetic data are interpreted correctly and applied consistently across inpatient and outpatient settings. Their role extends to formulary management, provider education, and protocol development—contributing to greater operational efficiency and higher patient satisfaction.
Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. December 21, 2004. Subscribe Now!
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.
Patients 18 years or older with inpatient admission to SMV were included in the review. Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medical record.
Cytokine release syndrome was seen in 78% (all grade 1 or 2), immune effector cell-associated neurotoxicity syndrome occurred in 12% (1% each grade 3 and 4; no grade 5), and neutropenia in 62% of trial participants. At 9 months, duration of response was 75%, progression-free survival was 64%, and overall survival was 80%.
Traditionally administered in inpatient or observation settings due to concerns of cytokine release syndrome (CRS) and other acute toxicities, step-up dosing (SUD) regimens have emerged as a strategy to mitigate these risks.
5 The Most Significant Driver of Health Care Spend Isn’t Drugs—It Isn’t Even Close Pharmaceutical manufacturers are a frequent punching bag for politicians, mostly because they are easy targets, and they tend to have more visible out-of-pocket exposure.
Pneumococcal disease remains a global threat, with vaccines recommended for at-risk groups, including children. Economic value assessments of pneumococcal vaccination are underreported, highlighting the need for updated utility studies.
Market Basket and Payment Rate Updates Hospital Inpatient Prospective Payment System Operating and Capital Payment Rate Updates The NHC is concerned about whether CMS’ proposed 2.4 5 A coordinated assessment of these methodologies is essential to avoid creating new disparities in Medicare inpatient payments.
In this episode, I’ll discuss a possible syndrome that might herald vaccine-induced immune thrombotic thrombocytopenia. Episode 646: Does vaccine-induced immune thrombotic thrombocytopenia have a “pre-VITT syndrome” ? All 11 patients presented with severe headache 5 to 18 days after adenovirus vector vaccination.
In this episode, I’ll discuss the CDC Recommendations if a patient develops COVID-19 before receiving the 2nd vaccine dose. Patients who get COVID-19 before their 2nd vaccine dose and are treated with a monoclonal antibody, and 2. This guidance also applies to people who get COVID-19 before getting their second dose of vaccine.
Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services. Part D plans will also cover most vaccines, except for those covered in Part B.
Breakdown of Medicare Types and Coverage Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services.
In this episode, I’ll discuss the use of tetanus immune globulin. Subscribe on iTunes , Android , or Stitcher Tetanus Immune Globulin can be part of successful tetanus post-exposure prophylaxis for certain patients as well as tetanus treatment. Peak concentrations are reached in 2 days and the half-life is 23 days.
This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
In this episode, I’ll discuss the use of tetanus immune globulin. Episode 535: Tetanus immune globulin Subscribe on iTunes , Android , or Stitcher Tetanus Immune Globulin can be part of successful tetanus post-exposure prophylaxis for certain patients as well as tetanus treatment. Prevent toxin production 4.
This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
In this episode, I’ll discuss when rabies immune globulin is indicated. Episode 687: How to decide when to give rabies immune globulin? Subscribe on iTunes , Android , or Stitcher Rabies immune globulin (RIG) administration is part of successful rabies post-exposure prophylaxis. The dose of RIG is 20 units/kg x 1.
- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content